These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25224652)

  • 1. Reversible covalent inhibition of eEF-2K by carbonitriles.
    Devkota AK; Edupuganti R; Yan C; Shi Y; Jose J; Wang Q; Kaoud TS; Cho EJ; Ren P; Dalby KN
    Chembiochem; 2014 Nov; 15(16):2435-42. PubMed ID: 25224652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the kinetic mechanism of inhibition of elongation factor 2 kinase by NH125: evidence of a common in vitro artifact.
    Devkota AK; Tavares CD; Warthaka M; Abramczyk O; Marshall KD; Kaoud TS; Gorgulu K; Ozpolat B; Dalby KN
    Biochemistry; 2012 Mar; 51(10):2100-12. PubMed ID: 22352903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular mechanism of eukaryotic elongation factor 2 kinase activation.
    Tavares CD; Ferguson SB; Giles DH; Wang Q; Wellmann RM; O'Brien JP; Warthaka M; Brodbelt JS; Ren P; Dalby KN
    J Biol Chem; 2014 Aug; 289(34):23901-16. PubMed ID: 25012662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of tagless recombinant human elongation factor 2 kinase (eEF-2K) expressed in Escherichia coli.
    Abramczyk O; Tavares CD; Devkota AK; Ryazanov AG; Turk BE; Riggs AF; Ozpolat B; Dalby KN
    Protein Expr Purif; 2011 Oct; 79(2):237-44. PubMed ID: 21605678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure prediction of eukaryotic elongation factor-2 kinase and identification of the binding mechanisms of its inhibitors: homology modeling, molecular docking, and molecular dynamics simulation.
    Tatar G; Taskin Tok T; Ozpolat B; Ay M
    J Biomol Struct Dyn; 2022; 40(24):13355-13365. PubMed ID: 30880628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the complex between calmodulin and a functional construct of eukaryotic elongation factor 2 kinase bound to an ATP-competitive inhibitor.
    Piserchio A; Isiorho EA; Dalby KN; Ghose R
    J Biol Chem; 2023 Jun; 299(6):104813. PubMed ID: 37172726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the domain structure of elongation factor-2 kinase by mutagenesis.
    Diggle TA; Seehra CK; Hase S; Redpath NT
    FEBS Lett; 1999 Aug; 457(2):189-92. PubMed ID: 10471776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of pyrido[2,3-d]pyrimidine-2,4-dione derivatives as eEF-2K inhibitors.
    Edupuganti R; Wang Q; Tavares CD; Chitjian CA; Bachman JL; Ren P; Anslyn EV; Dalby KN
    Bioorg Med Chem; 2014 Sep; 22(17):4910-6. PubMed ID: 25047940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting elongation factor-2 kinase (eEF-2K) induces apoptosis in human pancreatic cancer cells.
    Ashour AA; Abdel-Aziz AA; Mansour AM; Alpay SN; Huo L; Ozpolat B
    Apoptosis; 2014 Jan; 19(1):241-58. PubMed ID: 24193916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium/calmodulin stimulates the autophosphorylation of elongation factor 2 kinase on Thr-348 and Ser-500 to regulate its activity and calcium dependence.
    Tavares CD; O'Brien JP; Abramczyk O; Devkota AK; Shores KS; Ferguson SB; Kaoud TS; Warthaka M; Marshall KD; Keller KM; Zhang Y; Brodbelt JS; Ozpolat B; Dalby KN
    Biochemistry; 2012 Mar; 51(11):2232-45. PubMed ID: 22329831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for the Recognition of Eukaryotic Elongation Factor 2 Kinase by Calmodulin.
    Lee K; Alphonse S; Piserchio A; Tavares CD; Giles DH; Wellmann RM; Dalby KN; Ghose R
    Structure; 2016 Sep; 24(9):1441-51. PubMed ID: 27499441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elongation factor-2 kinase (eEF-2K) expression is associated with poor patient survival and promotes proliferation, invasion and tumor growth of lung cancer.
    Bircan HA; Gurbuz N; Pataer A; Caner A; Kahraman N; Bayraktar E; Bayraktar R; Erdogan MA; Kabil N; Ozpolat B
    Lung Cancer; 2018 Oct; 124():31-39. PubMed ID: 30268477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal Integration at Elongation Factor 2 Kinase: THE ROLES OF CALCIUM, CALMODULIN, AND SER-500 PHOSPHORYLATION.
    Tavares CDJ; Giles DH; Stancu G; Chitjian CA; Ferguson SB; Wellmann RM; Kaoud TS; Ghose R; Dalby KN
    J Biol Chem; 2017 Feb; 292(5):2032-2045. PubMed ID: 27956550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and expression of cDNA encoding protein synthesis elongation factor-2 kinase.
    Redpath NT; Price NT; Proud CG
    J Biol Chem; 1996 Jul; 271(29):17547-54. PubMed ID: 8663182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elongation factor-2 kinase regulates TG2/β1 integrin/Src/uPAR pathway and epithelial-mesenchymal transition mediating pancreatic cancer cells invasion.
    Ashour AA; Gurbuz N; Alpay SN; Abdel-Aziz AA; Mansour AM; Huo L; Ozpolat B
    J Cell Mol Med; 2014 Nov; 18(11):2235-51. PubMed ID: 25215932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the impact of eukaryotic elongation factor 2 kinase on cancer: A systematic review.
    Li S; Li Y; Bai Y
    Eur J Pharmacol; 2019 Aug; 857():172470. PubMed ID: 31226250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of elongation factor-2 kinase by pH.
    Dorovkov MV; Pavur KS; Petrov AN; Ryazanov AG
    Biochemistry; 2002 Nov; 41(45):13444-50. PubMed ID: 12416990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of elongation factor-2 kinase differentially regulates the enzyme's stability under stress conditions.
    Huber-Keener KJ; Evans BR; Ren X; Cheng Y; Zhang Y; Hait WN; Yang JM
    Biochem Biophys Res Commun; 2012 Jul; 424(2):308-14. PubMed ID: 22749997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel compounds, '1,3-selenazine derivatives' as specific inhibitors of eukaryotic elongation factor-2 kinase.
    Cho SI; Koketsu M; Ishihara H; Matsushita M; Nairn AC; Fukazawa H; Uehara Y
    Biochim Biophys Acta; 2000 Jul; 1475(3):207-15. PubMed ID: 10913818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymoquinone inhibits cell proliferation, migration, and invasion by regulating the elongation factor 2 kinase (eEF-2K) signaling axis in triple-negative breast cancer.
    Kabil N; Bayraktar R; Kahraman N; Mokhlis HA; Calin GA; Lopez-Berestein G; Ozpolat B
    Breast Cancer Res Treat; 2018 Oct; 171(3):593-605. PubMed ID: 29971628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.